Thrivory, Inc.

Thrivory, Inc. is a US-based company that revolutionizes the insurance reimbursement process for healthcare providers, enabling immediate cash flow through advanced funding against submitted claims. Thrivory, Inc. was founded in 2023 in Oradell, US, focusing on advancing funds to healthcare providers based on their submitted claims.

The company has secured a total of USD 3. 5 mn in funding, led by Redesign Health, following its most recent funding round in November 2025. The founder's prior ventures are not specified, but Thrivory has completed 2 deals to date. Thrivory specializes in a platform that accelerates insurance reimbursements for healthcare providers, allowing them to access a significant portion of expected payments almost immediately upon claim submission.

Their services support independent medical practices and integrate with various billing workflows, accommodating numerous commercial and government payors, including AARP Medicare, Aetna, Blue Cross Blue Shield, and UnitedHealthcare. Thrivory's solution targets practices across the US seeking to enhance cash flow management. Thrivory generates revenue primarily through fees related to advance payments made to healthcare providers. The company offers advancements typically around 80% of the anticipated reimbursement amount, collecting the advance along with a flat transaction fee upon payment from the payer.

This model avoids traditional lending structures, focusing instead on claim purchases to eliminate debt liabilities for clients. Additionally, Thrivory charges an annual fee for onboarding and monitoring services, promoting transparency in its pricing. Following a funding round in November 2025, where Thrivory raised USD 3. 5 mn, the company plans to scale its ThriveNow API and enhance its risk models and analytics.

This financial backing will support the expansion of its underwriting and treasury operations for real-time healthcare payments. Thrivory is also looking to penetrate new geographic markets and regions, although specific locations and timelines for this expansion have not been disclosed.